Background-We previously characterized a novel K ϩ current (I KH ) with properties of constitutively active acetylcholinerelated current in dog atrium. I KH is sensitive to tertiapin-Q (IC 50 Ϸ10 nmol/L), a highly selective Kir3 current blocker. This study assessed the role of I KH in atrial tachycardia (AT)-remodeled canine left atrium (LA) with the use of tertiapin-Q as a probe. Methods and Results-Dogs were subjected to 7 to 13 days of AT (400 bpm). Coronary-perfused LA preparations were studied intact or subjected to cardiomyocyte isolation. I KH was recorded with patch-clamp methods. AT pacing increased time-dependent hyperpolarization-activated current (I KH ) at Ϫ110 mV from Ϫ1.8Ϯ0.3 (control) to Ϫ3.4Ϯ0.5 pA/pF (AT) and the 100-nmol/L tertiapin-sensitive component from Ϫ1.5Ϯ0.4 (control) to Ϫ3.3Ϯ0.6 pA/pF (AT). Prolonged atrial tachyarrhythmias could be induced with single extrastimuli in AT-remodeled, but not control, preparations, reflecting the atrial fibrillation-promoting effects of AT remodeling. In AT-remodeled preparations, tachyarrhythmia duration averaged 11.0Ϯ5.2 seconds, with a cycle length of 108Ϯ6 ms. Tertiapin-Q decreased tachyarrhythmia duration (to 0.6Ϯ0.1 second; PϽ0.001) and increased tachyarrhythmia cycle length (to 175Ϯ10 ms; PϽ0.001). Atrial action potential duration (APD) was increased 65Ϯ6% by tertiapin in AT-remodeled hearts versus 19Ϯ2% (PϽ0.001) in control. In 2 AT-remodeled preparations, tachyarrhythmia lasted uninterrupted for Ͼ20 minutes; tertiapin-Q slowed and then terminated arrhythmia in both. Tertiapin had no effect on left ventricular cardiomyocyte currents or APD. Conclusions-AT remodeling increases I KH , and a highly selective Kir3 current antagonist, tertiapin-Q, increases APD and suppresses atrial tachyarrhythmias in AT-remodeled preparations without affecting ventricular electrophysiology. Constitutive acetylcholine-related K ϩ current contributes to AT-remodeling effects in dogs and is a potentially interesting antiarrhythmic target. (Circulation. 2006;113:1730-1737.) 
A trial fibrillation (AF) is the most common sustained cardiac arrhythmia. Present antiarrhythmic drug approaches for sinus rhythm maintenance suffer from limited efficacy and a significant risk of adverse effects, particularly proarrhythmia. 1 One potential approach to improving drug therapy is the identification of novel ionic targets. 2 We have previously identified a time-dependent inwardly rectifying Clinical Perspective p 1737 K ϩ current (I KH ) in canine atrial myocytes. I KH is highly sensitive to the specific inward rectifier current blocking compound tertiapin. 3 In cardiac tissue, tertiapin is a highly selective blocker of channels carried by the Kir3 subunits that underlie the acetylcholine-dependent K ϩ current I KACh . In our previous study we obtained extensive evidence indicating that I KH is a constitutively active form of I KACh . 3 I KH is increased by ␤-adrenergic stimulation and appears to be enhanced by sustained atrial tachycardia. 3 Because I KH contributes to atrial action potential repolarization, 3 it is a potential ionic determinant of the occurrence of AF and could constitute a novel ionic target for AF therapy.
The only selective I KH blocker presently available is tertiapin-Q, but tertiapin-Q is not available in sufficient quantities for in vivo administration under conditions that can produce and maintain stable and effective plasma concentrations. We recently showed that the atrial tachyarrhythmia-promoting effect of atrial tachycardia remodeling can be demonstrated in isolated coronary artery-perfused canine left atrial (LA) preparations. 4 Such preparations demonstrate accelerated atrial repolarization and readily inducible atrial tachyarrhythmias, unlike control preparations in which programmed stimulation rarely induces repetitive responses (which in turn never consist of more than a few beats). 4 Tertiapin-Q can be added to the perfusate of atrial tachycardia-remodeled preparations at known and effective Kir3 current-blocking concentrations. We therefore designed the present studies to assess the actions of tertiapin-Q on atrial repolarization and tachyarrhythmias in tachycardiaremodeled atrial preparations. In addition, we evaluated the effects of atrial tachycardia remodeling on Kir3-based currents as reflected by tertiapin-Q-sensitive current and the atrial specificity of I KH by studying the impact of tertiapin-Q exposure on ionic currents and action potential properties of canine ventricular cells.
Methods

Animal Model
All animal care procedures followed Canadian Council on Animal Care guidelines and were approved by the animal research ethics committee of the Montreal Heart Institute. Mongrel dogs weighing 20 to 30 kg were studied, with 3 control dogs and 8 tachycardia-remodeled dogs used for standard microelectrode experiments in multicellular preparations, 9 control and 4 tachycardia-remodeled dogs used for measurement of I KH -sensitive and atrial tertiapin-Q-sensitive currents, and 5 control dogs used to study the effects of tertiapin-Q on ventricular ionic currents and action potentials.
Dogs (Forest & Grenier, Inc, Boucherville; Laka, St-Basile-le-Grand; and Raymond Mailloux, Ste-Angèle-de-Monnoir, Quebec, Canada) subjected to atrial tachycardia remodeling were initially anesthetized with diazepam (0.25 mg/kg IV), ketamine (5.0 mg/kg IV), and halothane (1% to 2%) for transvenous insertion of right ventricular and right atrial unipolar pacing leads connected to ventricular and atrial pacemakers implanted in the neck. Atrioventricular block was created by radiofrequency catheter ablation, and atrial pacing was begun 24 hours after pacemaker implantation, after which the right atrium was tachypaced (400 bpm) for 7 to 13 days. The right ventricular demand pacemaker was programmed to 80 bpm to prevent excess bradycardia after induction of atrioventricular block.
On study days, dogs were anesthetized with pentobarbital (30 mg · kg Ϫ1 IV) and artificially ventilated. Hearts and adjacent lung tissue were excised via a left thoracotomy and immersed in oxygenated Tyrode's solution. For atrial cell isolation, the proximal left circumflex coronary artery was cannulated, and left atria were perfused with solution containing collagenase (100 U · mL Ϫ1 , Worthington, type II), as previously described. 4 For ventricular cell isolation, the transmural free wall (Ϸ30ϫ50 mm) of the anterolateral left ventricle, perfused by coronary artery branches from the left circumflex coronary artery, was quickly dissected, and the artery was cannulated. Cell isolation was performed as previously described 5 by perfusion with Tyrode's solution containing collagenase (120 U/mL, Worthington, type II). After isolation, cells were kept in storage solution (for contents, see below) at 4°C and studied within 12 hours.
For standard microelectrode experiments and atrial tachyarrhythmia induction, intact tissue preparations including the LA and adjacent pulmonary veins were mounted in a Plexiglas chamber (Ridout Plastics Co, Inc, San Diego, Calif). The preparations were simultaneously superfused at 10 mL/min and perfused via the left circumflex coronary artery with oxygenated solution at 36Ϯ0.5°C. Fine-tipped floating microelectrodes (resistance 15 to 20 M⍀ when filled with 3 mol/L KCl) coupled to a high-input impedance amplifier were used to record action potentials as previously described. 4 Action potential duration (APD) was determined to 50% and 90% repolarization (APD 50 and APD 90 , respectively).
For atrial tachyarrhythmia induction, we used single S2 extrastimuli at multiple sites after 15 basic S1 stimuli at cycle lengths of 200 to 500 ms, with a 5-second pause to observe the response. At each site, the effective refractory period (ERP) was first identified by decrementing the S1S2 interval by 10 ms from 50 to 100 ms below the basic cycle length, and the shortest S1S2 inducing a response above the ERP was tested. The S1S2 interval was then increased by 10-ms increments until the S1S2 interval was Ͼ30 ms above the ERP. This protocol was repeated 3 times at each cycle length tested (500, 333, 250, 200 ms), until a tachyarrhythmia was induced or until all S1S2s at all cycle lengths specified by the protocol were studied without tachyarrhythmia induction. The same protocol was performed before and after tertiapin-Q infusion. This protocol tended to minimize the inducibility differences between conditions before and after tertiapin because it did not consider the ease of tachyarrhythmia induction, which was often much greater before tertiapin (when tachyarrhythmias were often induced during the ERP determination at the first cycle length studied) versus after the drug (when tachyarrhythmias could often be induced only on completing nearly the full induction protocol).
To study ventricular action potentials, ventricular free-wall multicellular preparations were perfused via the circumflex coronary artery (as performed for cell isolation) and simultaneously superfused at 10 mL/min in a Plexiglas chamber for standard microelectrode recording. All stimuli were twice-threshold, 2-ms pulses.
Cellular Electrophysiology
Currents were recorded with whole-cell patch-clamp methods at 36Ϯ0.5°C. Borosilicate glass patch-clamp electrodes had tip resistances between 1.5 and 3.0 M⍀ when filled. Compensated series resistance and capacitive time constants averaged 3.1Ϯ0.2 mol/L⍀ and 0.27Ϯ0.01 ms, respectively. In some experiments, cell access was obtained with the use of the perforated-patch technique. Rather than rupturing cell membranes by suction, the pipette tip was filled with normal intracellular solution, and then the pipette shaft was filled by injecting nystatin-containing (400 g/mL) intracellular solution. After seal formation, the series resistance decreased progressively to reach a stable value averaging 7.7Ϯ0.6 M⍀. Atrial cell capacitance averaged 89.3Ϯ4.1 picofarad (pF), and left ventricular cell capacitance averaged 188.5Ϯ7.9 pF. To control for cell size variability, currents are expressed as densities (picoamperes [pA]/ pF). Junction potentials averaged 9.7Ϯ0.7 mV and were not compensated. Currents were recorded with hyperpolarizing and depolarizing pulses (4-second duration) from a holding potential of Ϫ40 mV to selected test potentials.
Solutions
The solution for cell storage contained the following (mmol/L): KCl 20, KH 2 PO 4 10, dextrose 10, mannitol 40, L-glutamic acid 70, ␤-OH-butyric acid 10, taurine 20, EGTA 10, and 0.1% bovine serum albumin (pH 7.3, KOH). Tyrode's (extracellular) solution contained the following (mmol/L): NaCl 136, KCl 5.4, MgCl 2 1, CaCl 2 1, NaH 2 PO 4 0.33, HEPES 5, and dextrose 10 (pH 7.35, NaOH). Nifedipine (10 mol/L) was used to inhibit L-type Ca 2ϩ current. 4-Aminopyridine (2 mmol/L) was added to suppress transient outward current (I to ). Atropine (100 nmol/L) was added to extracellular solutions to suppress muscarinic receptor-activated currents. The internal solution contained the following (mmol/L): potassium aspartate 110, KCl 20, MgCl 2 1, MgATP 5, GTP (lithium salt) 0.1, HEPES 10, sodium phosphocreatinine 5, and EGTA 5.0 (pH 7.3, KOH). Nystatin was prepared freshly each day that it was used and dissolved into intracellular solution at the desired concentration. For standard microelectrode experiments, a solution containing (mmol/L) NaCl 120, KCl 4, KH 2 PO 4 1.2, MgSO 4 1.2, NaHCO 3 25, CaCl 2 1.25, and dextrose 5 (95% O 2 /5% CO 2 , pH 7.4) was used to perfuse the tissue. The highly selective Kir3 channel blocker tertiapin-Q and all other chemicals unless otherwise stated were obtained from Sigma-Aldrich Chemical Co (St Louis, Mo).
Data Analysis
Clampfit 6.0 (Axon Instruments, Foster City, Calif) and GraphPad Prism 3.0 (GraphPad Software, Inc, San Diego, Calif) were used for data analysis. Group data are presented as meanϮSEM. Two-way repeated-measures ANOVA was used to study the behavior of the 2 groups (control and atrial tachycardia) across voltages. Two-group t test was used to study the effect of atrial tachycardia on the tertiapin-induced percent increase in APD 50 and APD 90 . Generalized estimating equations were used to model AF duration and tachycardia cycle length before versus after tertiapin-Q, as well as APD values before and after tertiapin. These models included before and after tertiapin-Q as factor and dog as the unit within which repeated observations were made. To analyze arrhythmia duration, which was found to have a skewed distribution, data were subjected to normalization by logarithmic transformation before statistical comparison. For atrial tachyarrhythmia inducibility analysis, the percentage of successful induction attempts (number of successes/ number of attempts) was computed for each dog, and the mean percentage of success in the 8 dogs before tertiapin-Q infusion was compared with the mean percentage of success in the same dogs in the presence of tertiapin-Q with a paired t test. A 2-tailed PϽ0.05 was considered to indicate a statistically significant difference.
The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results
Atrial Tachycardia-Induced Remodeling of I KH Figure 1A shows currents elicited by 4-second pulses from a holding potential of Ϫ40 mV to voltages between Ϫ120 and Ϫ30 mV with 10-mV increments under control conditions. I KH is seen as a typical time-dependent activating current with small outward tail currents. There is also an instantaneous component that includes I K1 . Currents were increased in LA cardiomyocytes from atrial tachypaced dogs, as illustrated by the recordings from a representative cell in Figure 1B . The middle panels in Figure 1A and 1B show currents from the same cells after exposure to 100 nmol/L tertiapin-Q, which suppresses I KH , leaving an instantaneous current that we have previously shown to be primarily I K1 . 3 The bottom panels show tertiapin-sensitive currents from the respective cells, obtained by digitally subtracting currents in the middle panels from those in the top panels. These tertiapin-sensitive currents are essentially pure I KH . 3 Mean data in Figure 1C show a significant increase in the time-dependent currents obtained in the absence of tertiapin (as in Figure 1A ) over a broad range of voltages. Overall time-dependent current averaged Ϫ1.8Ϯ0.3 pA/pF at Ϫ110 mV in 18 control cells from 9 dogs versus Ϫ3.4Ϯ0.5 pA/pF in 10 cells from 4 tachypacingremodeled dogs. Mean tertiapin-sensitive current-voltage relations are shown in Figure 1D . Atrial tachypacing clearly increased tertiapin-Q-sensitive current. Tertiapin-sensitive current could be measured on the basis of stable recordings from the same cells both before and after the drug in 9 cells from 6 control dogs and 8 cells from 3 atrial tachycardia-remodeled dogs. The tertiapin-sensitive current at Ϫ110 mV averaged Ϫ1.5Ϯ0.4 pA/pF in control cells compared with Ϫ3.3Ϯ0.6 pA/pF in atrial tachycardiaremodeled cells.
Changes in APD Caused by Tachycardia Remodeling and Tertiapin Exposure
To assess the role of I KH in repolarization of atrial tachycardia-remodeled preparations, we monitored APD before and after exposure to tertiapin-Q. Figure 2A shows Bottom, Tertiapin-sensitive currents obtained in cells illustrated above by subtracting currents in presence of 100 nmol/L tertiapin-Q from currents before drug superfusion. C, MeanϮSEM I KH density-voltage relations based on time-dependent activating current based on 18 cells from 9 dogs for control vs 10 cells from 4 dogs for atrial tachycardia. Currents in AT dog cells were significantly greater than in control cells (Pϭ0.02). D, MeanϮSEM tertiapin-sensitive current densities based on nϭ9 cells from 6 dogs for control and 8 cells from 3 dogs for atrial tachycardia. Currents in atrial tachycardia dog cells were significantly larger than in control cells (Pϭ0.02). TP indicates test potential.
typical LA action potentials recorded at 2 Hz in a preparation from a control dog before (left) and in the presence of (right) 100 nmol/L tertiapin-Q. The drug clearly delayed action potential repolarization. Tertiapin increased APD values to both 90% (APD 90 ) and 50% (APD 50 ) repolarization: from 202.6Ϯ2.6 and 126.6Ϯ2.1 ms (at 2 Hz) in the absence of tertiapin to 242.7Ϯ6.2 and 146.8Ϯ3.2 ms, respectively, after tertiapin (PϽ0.05 for both; nϭ25; 12 cells before and after tertiapin, respectively, in 3 dogs each). Figure 2B shows action potentials in a preparation from a tachycardia-remodeled dog in the absence of tertiapin (left) and in the presence of the drug at 100 nmol/L (right). Atrial tachypacing produced marked APD abbreviation, and tertiapin clearly increased APD in the tachycardia-remodeled preparation. Figure 2C shows meanϮSEM APD 90 and APD 50 recorded at 2 Hz before and after tertiapin in control preparations (left) and atrial tachycardia-remodeled preparations (right). Tachycardia remodeling decreased APD significantly, eg, APD 90 was reduced from 202.6Ϯ2.6 ms in control (nϭ25 cells from 3 dogs) to 100.1Ϯ2.6 ms in tachycardia-remodeled preparations (nϭ24 cells from 8 dogs; PϽ0.001). Tertiapin significantly increased APD in both control and remodeled atria. Figure 2D shows mean percent APD increases produced by tertiapin relative to predrug values in control (left) and atrial tachycardia-remodeled (right) dogs. Overall, tertiapin increased APD 90 by 19Ϯ2% and APD 50 by 16Ϯ2% in control dogs compared with 65Ϯ6% (APD 90 ) and 100Ϯ9% (APD 50 ) in atrial tachycardia-remodeled dogs (PϽ0.001 versus effect in control for each). The larger effect of tertiapin in tachycardia-remodeled preparations is consistent with the upregulation of tertiapin-sensitive current associated with atrial tachycardia remodeling ( Figure 1D ).
To analyze further the effects of tertiapin-Q on repolarization, we fitted the slopes of phases 1 and 3 of the action potentials, as illustrated by the dotted and dashed lines, respectively, in Figure 2A and 2B. Phase 1 slope averaged 0.81Ϯ0.06 mV/ms in 25 cells from 3 control dogs and increased to 3.09Ϯ0.33 mV/ms (PϽ0.001) in 24 cells from 8 tachycardia-remodeled dogs. Tertiapin-Q had little effect on phase 1 slope in 3 control dogs (0.72Ϯ0.05 mV/ms; nϭ12 cells; PϭNS versus control before tertiapin-Q) but considerably decreased phase 1 slope in 23 remodeled cells from 8 dogs, to 1.12Ϯ0.15 mV/ms (PϽ0.001 versus values before tertiapin), almost to control levels. Phase 3 slope averaged 0.52Ϯ0.01 mV/ms before and 0.51Ϯ0.02 mV/ms after tertiapin-Q in control dogs (PϭNS). Atrial tachycardia remodeling increased phase 3 slope to 0.74Ϯ0.02 mV/ms (PϽ0.001 versus control), and this value was significantly reduced by tertiapin-Q, to 0.45Ϯ0.02 mV/ms (PϽ0.001 versus values before tertiapin in remodeled cells), to values comparable to those of control dogs.
The very strong inward rectification of I KH (Figure 1 ) makes it hard to understand its role in repolarization, as shown in Figure 2 . One possible explanation is that dialysis of cellular contents under tight-seal patch clamp alters intracellular composition in a fashion that enhances rectification. We therefore recorded I KH with perforated-patch methods before and after tertiapin-Q (100 nmol/L) in 11 cells from 5 additional dogs. The current-voltage curve between Ϫ70 and Ϫ40 mV from these cells is compared with those in 9 cells from 6 control dogs in Figure 3 . The outward currents are larger in cells studied with nystatin patch. To analyze inward rectification, we expressed the current for each cell at each voltage between Ϫ70 and Ϫ40 mV as a ratio of the inward current at Ϫ120 mV. This index was significantly larger (PϽ0.05, 2-factor repeated-measures ANOVA) for cells studied with the perforated-patch technique (eg, at Ϫ60 mV, 0.08Ϯ0.04 versus Ϫ0.07Ϯ0.07 for ruptured patch), indicat- APD changes due to atrial tachypacing and tertiapin-Q (TQ). A, Action potential recordings at 2 Hz obtained before and after tertiapin (100 nmol/L) in a preparation from a control dog. B, Action potential recordings at 2 Hz before and after tertiapin (100 nmol/L) in a preparation from an atrial tachycardia (AT)-remodeled dog. Note the strong APD abbreviation seen with atrial tachycardia remodeling and the APD increases produced by tertiapin. The dotted and dashed lines show phase 1 and phase 3 slopes, respectively. Bars indicate zero voltage. C, MeanϮSEM APD in the absence and presence of 100 nmol/L tertiapin-Q in control (CTL; left) and atrial tachycardia-remodeled (right) preparations. nϭ25, 12 cells before and after tertiapin-Q, respectively, in 3 dogs for control; nϭ24, 23 cells before and after tertiapin-Q, respectively, from 8 dogs in atrial tachycardia-remodeled preparations. D, Percent increase in APD caused by tertiapin-Q in control (left) and atrial tachycardia-remodeled (right) preparations based on the analysis of the data illustrated in C. *PϽ0.001 vs control.
ing less inward rectification with perforated-patch compared with tight-seal recording. Figure 4A shows the induction of an atrial tachyarrhythmia by a single extrastimulus in an atrial tachycardia-remodeled preparation. Figure 4B shows failure of tachyarrhythmia induction by an extrastimulus just beyond the refractory period in the same preparation after the addition of 100 nmol/L tertiapin-Q to the perfusate. Overall, in the absence of tertiapin, atrial tachyarrhythmias were induced by single extrastimuli in 81 of 117 attempts (65Ϯ5% of attempts) in preparations from 8 dogs. After tertiapin-Q infusion, atrial tachyarrhythmias could only be induced in 66 of 174 attempts (34Ϯ5%; Pϭ0.0025) in the same preparations.
Effects of Tertiapin-Q on Atrial Tachyarrhythmias
In addition to suppressing the induction of tachyarrhythmias in tachycardia-remodeled preparations, tertiapin-Q substantially reduced their persistence. In the absence of tertiapin-Q, mean tachyarrhythmia duration for nonsustained episodes was 11.0Ϯ5.2 seconds, with a mean cycle length of 108Ϯ6 ms. In the presence of 100 nmol/L tertiapin-Q, tachyarrhythmia duration was decreased significantly to 0.6Ϯ0.1 second (PϽ0.001), and tachyarrhythmia cycle length increased to 175Ϯ10 ms (PϽ0.001). In 2 separate tachycardia-remodeled preparations, tachyarrhythmias were spontaneously sustained for Ͼ20 minutes. An example of action potential recordings during a sustained tachyarrhythmia from 1 such preparation is shown in Figure 5A . In both cases, the addition of tertiapin-Q during sustained tachyarrhythmia caused progressive slowing of the tachycardia, with termination occurring on equilibration of the drug in the bath (within 4 minutes), as illustrated in Figure 5B .
Assessment of Potential Ventricular Effects of Tertiapin-Q
The aforementioned experiments indicate that tertiapin produces prominent APD increases in tachycardia-remodeled atrial preparations and alters the properties of tachyarrhythmias by decreasing their inducibility, reducing their duration, prolonging their cycle length, and terminating sustained episodes. To establish the atrial selectivity of tertiapin-Q and its target current, we performed the experiments illustrated in Figure 6 . Currents were recorded from single ventricular myocytes ( Figure 6A) with the same voltage protocol as used for atrial I KH recording ( Figure 6A) . A representative set of recordings from 1 ventricular myocyte is shown in the top panel. In no cases was current with the typical time-dependent properties of I KH observed. The bottom panel shows currents from the same cell after administration of tertiapin-Q. There was no apparent change. Figure  6B shows mean current density-voltage relations before and after tertiapin-Q in 10 ventricular myocytes from 2 dogs. No significant effect of tertiapin-Q was observed. For example, at Ϫ110 mV, the current density averaged Ϫ38.0Ϯ2.9 pA/pF before and Ϫ39.4Ϯ3.6 pA/pF after the addition of 100 nmol/L tertiapin-Q. Figure 6C shows typical ventricular action potentials recorded before (top) and after (bottom) tertiapin-Q exposure in one multicellular ventricular preparation. In contrast to its clear effect on atrial tissues (Figure 2) , tertiapin had no apparent effect on ventricular action potentials. Mean APD data ( Figure 5D ) confirm the lack of any significant effect of tertiapin-Q on ventricular repolarization.
Discussion
In this study we found that atrial tachycardia remodeling increases the tertiapin-Q-sensitive atrial current I KH . In addition, tertiapin-Q importantly prolonged repolarization, prevented tachyarrhythmia induction, and suppressed sustained tachyarrhythmias in tachycardia-remodeled atrial preparations. In contrast to its important atrial effects, tertiapin-Q produced no detectable changes in ventricular ionic currents or action potentials.
Ionic Changes in AT Remodeling
Atrial tachycardia-induced electric remodeling plays a significant role in the pathophysiology of AF. 6, 7 Alterations in ion channel function ("ionic remodeling") are believed to be important in the AF-promoting consequences of atrial tachycardia. 6 -8 Ionic changes that have been reported include decreased transient outward current (I to ), 9 -11 L-type Ca 2ϩ current (I Ca ) 9, 11, 12 and Na ϩ current (I Na ), 13, 14 and increased inward rectifier K ϩ currents. 10, 11, 15 Bosch et al 11 reported that atrial myocytes from AF patients show increases in both the background inward rectifier current I K1 and the acetylcholineinduced component. In contrast, Dobrev et al 15 showed that in myocytes from AF patients the background inward rectifier current is increased, but the acetylcholine-induced component is reduced. We also found that the additional current induced by cholinergic stimulation is reduced in atrial myocytes from tachycardia-remodeled dog atria but that the constitutive I KACh component (I KH ) is enhanced. 3 In previous work, we quantified the constitutive component in tachycardia-remodeled myocytes on the basis of its time dependence and found it to be enhanced relative to time-dependent constitutive current in control dogs. 3 In that study the response of currents to tertiapin was not examined in remodeled preparations. 3 In the present investigation we show that atrial tachycardia significantly enhances the current component sensitive to tertiapin-Q, accounting for the increased APD response to tertiapin seen in remodeled preparations. Tertiapin-Q is a highly selective blocker of currents encoded by Kir1 and Kir3 subunits, 16 and in the heart (which lacks Kir1 currents) tertiapin-Q blocks the Kir3-based channels that carry I KACh very selectively at concentrations up to 1 mol/L. 17, 18 I KACh channels can be constitutively active in the absence of cholinergic agonist stimulation, 19, 20 as must be the case for I KH , because the current is robust in the presence of the muscarinic antagonist atropine. Furthermore, cholinergic K ϩ currents with kinetic properties similar to those of I KH have been observed previously in human atrial myocytes. 21 AF-promoting conditions like atrial tachycardia-induced remodeling produce a wide range of functional alterations. It is a significant challenge to determine the role of specific changes in AF promotion. 22 Such knowledge is needed to appreciate therapeutic implications and to develop effective new therapeutic approaches. I Ca reduction clearly contributes to action potential abbreviation in atrial tachycardia remodeling. 9, 11, 12 The potential importance of inward rectifier current changes 10, 11, 15 has remained speculative. In the present study we provide strong evidence for a role of increased constitutively active I KACh /I KH by showing that tertiapin-Q at highly selective Kir3-blocking concentrations suppresses K ϩ current and increases APD in tachycardia-remodeled atria to Figure 6 . A, Typical current recordings in a canine left ventricular cell before (CTL) and after (TQ) 100 nmol/L tertiapin-Q, obtained with the same voltage protocols as I KH recordings in Figure 1A and 1B . B, MeanϮSEM current density-voltage relations in control and after tertiapin-Q from 10 cells (2 dogs) studied before and after tertiapin-Q showed no significant differences. TP indicates test potential. C, Typical action potentials recorded at 2 Hz in the absence (top, CTL) and presence (bottom) of tertiapin-Q (100 nmol/L). Bars indicate zero voltage. D, MeanϮSEM APD at 90% (APD 90) and 50% (APD 50) repolarization before (CTL; 15 cells, 3 dogs) and after (TQ; 24 cells, 3 dogs) tertiapin-Q exposure. a greater extent than in control atria and suppresses tachyarrhythmia induction and maintenance in tachycardia-remodeled preparations.
Potential Importance of our Findings
The pathophysiological relevance and potential therapeutic importance of atrial tachycardia remodeling are well recognized. 6, 7 Insights into underlying mechanisms are therefore of considerable significance. Our study is the first, to our knowledge, to demonstrate experimentally a role for Kir3based inward rectifier currents in the ionic current changes, action potential alterations, and arrhythmia promotion caused by atrial tachycardia remodeling. Furthermore, these findings support the results of recent modeling work, which predicts a significant role of inward rectifying currents in stabilizing atrial reentrant arrhythmias. 23 The therapeutic options for AF are presently suboptimal, and there is an ongoing search for drugs that can suppress AF without promoting ventricular tachyarrhythmias. In the present study we found that tertiapin-Q suppresses atrial tachyarrhythmias in atrial tachycardia-remodeled preparations at concentrations that have no effect on ventricular myocyte currents or action potentials. Thus, Kir3-based I KACh is a potentially interesting target for atrial-selective antiarrhythmic drug development. A variety of traditional antiarrhythmic agents have I KACh -blocking ability. 24 -26 The investigational compound AVE-0118 also blocks I KACh 27 and has interesting efficacy in experimental AF. 28 Thus, I KACh inhibition can apparently be achieved safely in vivo and may contribute to antiarrhythmic efficacy. Furthermore, there is evidence of constitutive I KACh activation in AF patients, 29 which can be unmasked by its tertiapin-sensitive properties. 30 In view of the results of the present study, the development of selective I KACh blockers may be an interesting new approach to consider for AF therapy.
Potential Limitations
Our experiments were performed in LA cardiomyocytes and multicellular preparations. The extent to which right atrial tissue would manifest similar properties is uncertain. However, given the apparent importance of LA drivers in AF, [31] [32] [33] our results would likely be of potential importance even if similar phenomena were absent in the right atrium. In fact, there is evidence that I KACh may be greater in the left than the right atrium, 34 which in combination with the findings of the present study would provide a candidate ionic mechanism for the role of the left atrium in AF associated with atrial tachycardia remodeling.
The current-voltage relations of I KH indicate very small currents at voltages positive to Ϫ30 mV, but we saw apparent action potential prolongation by tertiapin-Q at more positive voltages. Furthermore, we saw a significant decrease in phase 1 slope with the compound. It is difficult to extrapolate directly from patch-clamp ion current recordings to ionic current properties in vivo. The conditions needed to record selected currents in native cells with tight-seal patch clamp involve a variety of factors that can significantly distort subtle current properties, including voltage dependence. Such factors include dialysis of intracellular contents with the patch pipette solution (which removes a variety of macromolecules and important cellular constituents), the need for strong intracellular buffering to prevent cytotoxic Ca 2ϩ overload, and the use of interventions (which can have significant effects on current amplitude, kinetics, and current-voltage relations) to block potential contaminating currents. We therefore relied on the use of a highly selective blocking compound (tertiapin-Q) in coronary artery-perfused multicellular preparations to provide information about the potential importance of I KH on repolarization and arrhythmia generation under the most physiological conditions possible. In previous studies with cardiac tissue, tertiapin blocked I KACh very potently, with an IC 50 of 8 to 30 nmol/L and no significant effect on rapid or slow delayed-rectifier K ϩ current, I K1 , adenosine triphosphate-dependent K ϩ current, sustained end-pulse outward current, Na ϩ current, or L-type Ca 2ϩ current. 17, 18 However, we cannot fully exclude an action of tertiapin-Q on some unknown current that differs from I KACh -related current and from others on which the drug has been tested previously.
